retatrutide mechanism glp-1 gip glucagon triple agonist phase 2 trial obesity First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, & hormone receptor GLP-1 Receptor Agonists | New
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 21 - Nov 26


























